These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8794666)

  • 1. [The neuropeptide cholecystokinin and anxiety states].
    Cohen H; Kaplan Z
    Harefuah; 1996 May; 130(10):707-10. PubMed ID: 8794666
    [No Abstract]   [Full Text] [Related]  

  • 2. The cholecystokinin hypothesis of anxiety and panic disorder.
    Bradwejn J; Koszycki D
    Ann N Y Acad Sci; 1994 Mar; 713():273-82. PubMed ID: 8185169
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholecystokinin and GABA interaction in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety.
    Rezayat M; Roohbakhsh A; Zarrindast MR; Massoudi R; Djahanguiri B
    Physiol Behav; 2005 Apr; 84(5):775-82. PubMed ID: 15885255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of GABA in memory and anxiety.
    Kalueff A; Nutt DJ
    Depress Anxiety; 1996-1997; 4(3):100-10. PubMed ID: 9166638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin enhances GABAergic inhibitory transmission in basolateral amygdala.
    Chung L; Moore SD
    Neuropeptides; 2007 Dec; 41(6):453-63. PubMed ID: 17904218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cholecystokinin in the induction of aggressive behavior: a focus on the available experimental data (review).
    Katsouni E; Zarros A; Skandali N; Tsakiris S; Lappas D
    Acta Physiol Hung; 2013 Dec; 100(4):361-77. PubMed ID: 24317345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin and anxiety: promises and pitfalls.
    Rodgers RJ; Johnson NJ
    Crit Rev Neurobiol; 1995; 9(4):345-69. PubMed ID: 8829850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenge studies in anxiety disorders.
    Keck ME; Ströhle A
    Handb Exp Pharmacol; 2005; (169):449-68. PubMed ID: 16594268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies.
    Harro J
    Amino Acids; 2006 Oct; 31(3):215-30. PubMed ID: 16738800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New directions in GABAergic pharmacology of anxiety and depression].
    Kaluev AV; Nutt DD
    Eksp Klin Farmakol; 2004; 67(6):3-7. PubMed ID: 15707004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocebo hyperalgesia: how anxiety is turned into pain.
    Colloca L; Benedetti F
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):435-9. PubMed ID: 17873596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA-ergic role in overlapping of memory and anxiety.
    Kaluiev AV
    Fiziol Zh (1994); 1998; 44(4):32-41. PubMed ID: 9669171
    [No Abstract]   [Full Text] [Related]  

  • 13. Anxiolytics: past, present, and future agents.
    Nemeroff CB
    J Clin Psychiatry; 2003; 64 Suppl 3():3-6. PubMed ID: 12662127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J; Koszycki D
    Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin in the control of ingestive behavior.
    Södersten P; Forsberg G; Bednar I; Lindén A; Qureshi GA
    Prog Brain Res; 1992; 92():335-43. PubMed ID: 1302882
    [No Abstract]   [Full Text] [Related]  

  • 16. Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues.
    Crestani F; Lorez M; Baer K; Essrich C; Benke D; Laurent JP; Belzung C; Fritschy JM; Lüscher B; Mohler H
    Nat Neurosci; 1999 Sep; 2(9):833-9. PubMed ID: 10461223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonhuman primate studies of fear, anxiety, and temperament and the role of benzodiazepine receptors and GABA systems.
    Kalin NH
    J Clin Psychiatry; 2003; 64 Suppl 3():41-4. PubMed ID: 12662133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.
    Kõks S; Männistö PT; Bourin M; Shlik J; Vasar V; Vasar E
    J Psychiatry Neurosci; 2000 Jan; 25(1):33-42. PubMed ID: 10721682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New problems in GABAergic pharmacology of anxiety].
    Kaluev AV
    Eksp Klin Farmakol; 1997; 60(5):3-7. PubMed ID: 9483395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurophysiology of anxiety].
    Debray Q; Galopin JC
    Soins Psychiatr; 1981 Mar; (8):3-5. PubMed ID: 6114564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.